[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Generic Drugs Market Size, Status and Forecast 2025

June 2018 | 103 pages | ID: GEADA2E20DFEN
QYResearch

US$ 3,300.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies the global Generic Drugs market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Generic Drugs market by companies, region, type and end-use industry.
In 2017, the global Generic Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global top players, covered
  • Teva Pharma
  • Novartis-Sandoz
  • Mylan
  • Sun Pharmaceutical
  • Aspen Pharmacare
  • Allergan
  • Fresenius Kabi
  • Pfizer (Hospira)
  • Sanofi
  • Aurobindo
  • Lupin
  • Dr. Reddy's Lab
  • Apotex
  • Cipla
  • ENDO (Par Pharmaceutical)
  • Stada
  • Krka Group
  • Nichi-Iko Pharmaceutical
  • Valeant
  • Zydus Cadila
  • Hikma
Market segment by Regions/Countries, this report covers
  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
Market segment by Type, the product can be split into
  • Simple Generic Drugs
  • Super Generic Drugs
  • Biosimilars
Market segment by Application, split into
  • CNS
  • Cardiovascular
  • Genitourinary/Hormonal Drugs
  • Respiratory
  • Rheumatology
  • Diabetes
  • Oncology
  • Others
The study objectives of this report are:
  • To study and forecast the market size of Generic Drugs in global market.
  • To analyze the global key players, SWOT analysis, value and global market share for top players.
  • To define, describe and forecast the market by type, end use and region.
  • To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
  • To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Generic Drugs are as follows:
  • History Year: 2013-2017
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Generic Drugs Manufacturers
Generic Drugs Distributors/Traders/Wholesalers
Generic Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Generic Drugs market, by end-use.
Detailed analysis and profiles of additional market players.
Global Generic Drugs Market Size, Status and Forecast 2025

1 INDUSTRY OVERVIEW OF GENERIC DRUGS

1.1 Generic Drugs Market Overview
  1.1.1 Generic Drugs Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Generic Drugs Market Size and Analysis by Regions (2013-2018)
  1.2.1 United States
  1.2.2 Europe
  1.2.3 China
  1.2.4 Japan
  1.2.5 Southeast Asia
  1.2.6 India
1.3 Generic Drugs Market by Type
  1.3.1 Simple Generic Drugs
  1.3.2 Super Generic Drugs
  1.3.3 Biosimilars
1.4 Generic Drugs Market by End Users/Application
  1.4.1 CNS
  1.4.2 Cardiovascular
  1.4.3 Genitourinary/Hormonal Drugs
  1.4.4 Respiratory
  1.4.5 Rheumatology
  1.4.6 Diabetes
  1.4.7 Oncology
  1.4.8 Others

2 GLOBAL GENERIC DRUGS COMPETITION ANALYSIS BY PLAYERS

2.1 Generic Drugs Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Teva Pharma
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Generic Drugs Revenue (Million USD) (2013-2018)
3.2 Novartis-Sandoz
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Generic Drugs Revenue (Million USD) (2013-2018)
3.3 Mylan
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Generic Drugs Revenue (Million USD) (2013-2018)
3.4 Sun Pharmaceutical
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Generic Drugs Revenue (Million USD) (2013-2018)
3.5 Aspen Pharmacare
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Generic Drugs Revenue (Million USD) (2013-2018)
3.6 Allergan
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Generic Drugs Revenue (Million USD) (2013-2018)
3.7 Fresenius Kabi
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Generic Drugs Revenue (Million USD) (2013-2018)
3.8 Pfizer (Hospira)
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Generic Drugs Revenue (Million USD) (2013-2018)
3.9 Sanofi
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Generic Drugs Revenue (Million USD) (2013-2018)
3.10 Aurobindo
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Generic Drugs Revenue (Million USD) (2013-2018)
3.11 Lupin
3.12 Dr. Reddy's Lab
3.13 Apotex
3.14 Cipla
3.15 ENDO (Par Pharmaceutical)
3.16 Stada
3.17 Krka Group
3.18 Nichi-Iko Pharmaceutical
3.19 Valeant
3.20 Zydus Cadila
3.21 Hikma

4 GLOBAL GENERIC DRUGS MARKET SIZE BY TYPE AND APPLICATION (2013-2018)

4.1 Global Generic Drugs Market Size by Type (2013-2018)
4.2 Global Generic Drugs Market Size by Application (2013-2018)
4.3 Potential Application of Generic Drugs in Future
4.4 Top Consumer/End Users of Generic Drugs

5 UNITED STATES GENERIC DRUGS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Generic Drugs Market Size (2013-2018)
5.2 United States Generic Drugs Market Size and Market Share by Players (2013-2018)
5.3 United States Generic Drugs Market Size by Application (2013-2018)

6 EUROPE GENERIC DRUGS DEVELOPMENT STATUS AND OUTLOOK

6.1 Europe Generic Drugs Market Size (2013-2018)
6.2 Europe Generic Drugs Market Size and Market Share by Players (2013-2018)
6.3 Europe Generic Drugs Market Size by Application (2013-2018)

7 CHINA GENERIC DRUGS DEVELOPMENT STATUS AND OUTLOOK

7.1 China Generic Drugs Market Size (2013-2018)
7.2 China Generic Drugs Market Size and Market Share by Players (2013-2018)
7.3 China Generic Drugs Market Size by Application (2013-2018)

8 JAPAN GENERIC DRUGS DEVELOPMENT STATUS AND OUTLOOK

8.1 Japan Generic Drugs Market Size (2013-2018)
8.2 Japan Generic Drugs Market Size and Market Share by Players (2013-2018)
8.3 Japan Generic Drugs Market Size by Application (2013-2018)

9 SOUTHEAST ASIA GENERIC DRUGS DEVELOPMENT STATUS AND OUTLOOK

9.1 Southeast Asia Generic Drugs Market Size (2013-2018)
9.2 Southeast Asia Generic Drugs Market Size and Market Share by Players (2013-2018)
9.3 Southeast Asia Generic Drugs Market Size by Application (2013-2018)

10 INDIA GENERIC DRUGS DEVELOPMENT STATUS AND OUTLOOK

10.1 India Generic Drugs Market Size (2013-2018)
10.2 India Generic Drugs Market Size and Market Share by Players (2013-2018)
10.3 India Generic Drugs Market Size by Application (2013-2018)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2018-2025)

11.1 Global Generic Drugs Market Size (Value) by Regions (2018-2025)
  11.1.1 United States Generic Drugs Revenue and Growth Rate (2018-2025)
  11.1.2 Europe Generic Drugs Revenue and Growth Rate (2018-2025)
  11.1.3 China Generic Drugs Revenue and Growth Rate (2018-2025)
  11.1.4 Japan Generic Drugs Revenue and Growth Rate (2018-2025)
  11.1.5 Southeast Asia Generic Drugs Revenue and Growth Rate (2018-2025)
  11.1.6 India Generic Drugs Revenue and Growth Rate (2018-2025)
11.2 Global Generic Drugs Market Size (Value) by Type (2018-2025)
11.3 Global Generic Drugs Market Size by Application (2018-2025)

12 GENERIC DRUGS MARKET DYNAMICS

12.1 Generic Drugs Market Opportunities
12.2 Generic Drugs Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Generic Drugs Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Generic Drugs Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Global Generic Drugs Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Generic Drugs Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Generic Drugs Market Share by Regions (2013-2018)
Figure United States Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Europe Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Generic Drugs Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Generic Drugs Revenue Market Share by Type in 2017
Figure Simple Generic Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Super Generic Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Biosimilars Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Generic Drugs Market Share by Application in 2017
Figure Generic Drugs Market Size (Million USD) and Growth Rate in CNS (2013-2018)
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Cardiovascular (2013-2018)
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Genitourinary/Hormonal Drugs (2013-2018)
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Respiratory (2013-2018)
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Rheumatology (2013-2018)
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Diabetes (2013-2018)
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Oncology (2013-2018)
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Others (2013-2018)
Table Generic Drugs Market Size (Million USD) by Players (2013-2018)
Figure Generic Drugs Market Size Share by Players in 2013
Figure Generic Drugs Market Size Share by Players in 2017
Table Teva Pharma Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Teva Pharma (2013-2018)
Figure Teva Pharma Generic Drugs Business Revenue Market Share (2013-2018)
Table Novartis-Sandoz Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Novartis-Sandoz (2013-2018)
Figure Novartis-Sandoz Generic Drugs Business Revenue Market Share (2013-2018)
Table Mylan Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Mylan (2013-2018)
Figure Mylan Generic Drugs Business Revenue Market Share (2013-2018)
Table Sun Pharmaceutical Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Sun Pharmaceutical (2013-2018)
Figure Sun Pharmaceutical Generic Drugs Business Revenue Market Share (2013-2018)
Table Aspen Pharmacare Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Aspen Pharmacare (2013-2018)
Figure Aspen Pharmacare Generic Drugs Business Revenue Market Share (2013-2018)
Table Allergan Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Allergan (2013-2018)
Figure Allergan Generic Drugs Business Revenue Market Share (2013-2018)
Table Fresenius Kabi Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Fresenius Kabi (2013-2018)
Figure Fresenius Kabi Generic Drugs Business Revenue Market Share (2013-2018)
Table Pfizer (Hospira) Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Pfizer (Hospira) (2013-2018)
Figure Pfizer (Hospira) Generic Drugs Business Revenue Market Share (2013-2018)
Table Sanofi Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Sanofi (2013-2018)
Figure Sanofi Generic Drugs Business Revenue Market Share (2013-2018)
Table Aurobindo Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Aurobindo (2013-2018)
Figure Aurobindo Generic Drugs Business Revenue Market Share (2013-2018)
Table Lupin Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Lupin (2013-2018)
Figure Lupin Generic Drugs Business Revenue Market Share (2013-2018)
Table Dr. Reddy's Lab Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Dr. Reddy's Lab (2013-2018)
Figure Dr. Reddy's Lab Generic Drugs Business Revenue Market Share (2013-2018)
Table Apotex Basic Information List
Table Cipla Basic Information List
Table ENDO (Par Pharmaceutical) Basic Information List
Table Stada Basic Information List
Table Krka Group Basic Information List
Table Nichi-Iko Pharmaceutical Basic Information List
Table Valeant Basic Information List
Table Zydus Cadila Basic Information List
Table Hikma Basic Information List
Table Global Generic Drugs Market Size (Million USD) by Product (2013-2018)
Figure Global Generic Drugs Revenue Market Share (%) by Product (2013-2018)
Figure Global Generic Drugs Market Share by Product in 2017
Table Global Generic Drugs Market Size by Application (2013-2018)
Figure Global Generic Drugs Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Generic Drugs
Figure United States Generic Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Generic Drugs Market Size (Million USD) by Players (2013-2018)
Figure United States Generic Drugs Market Size Share by Players in 2013
Figure United States Generic Drugs Market Size Share by Players in 2017
Table United States Generic Drugs Market Size by Application (2013-2018)
Figure United States Generic Drugs Revenue Market Share (%) by Application (2013-2018)
Figure United States Generic Drugs Market Size Share by Application in 2017
Figure Europe Generic Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Europe Generic Drugs Market Size (Million USD) by Players (2013-2018)
Figure Europe Generic Drugs Market Size Share by Players in 2013
Figure Europe Generic Drugs Market Size Share by Players in 2017
Table Europe Generic Drugs Market Size by Application (2013-2018)
Figure Europe Generic Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Europe Generic Drugs Market Size Share by Application in 2017
Figure China Generic Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table China Generic Drugs Market Size (Million USD) by Players (2013-2018)
Figure China Generic Drugs Market Size Share by Players in 2013
Figure China Generic Drugs Market Size Share by Players in 2017
Table China Generic Drugs Market Size by Application (2013-2018)
Figure China Generic Drugs Revenue Market Share (%) by Application (2013-2018)
Figure China Generic Drugs Market Size Share by Application in 2017
Figure Japan Generic Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Generic Drugs Market Size (Million USD) by Players (2013-2018)
Figure Japan Generic Drugs Market Size Share by Players in 2013
Figure Japan Generic Drugs Market Size Share by Players in 2017
Table Japan Generic Drugs Market Size by Application (2013-2018)
Figure Japan Generic Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Japan Generic Drugs Market Size Share by Application in 2017
Figure Southeast Asia Generic Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Generic Drugs Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Generic Drugs Market Size Share by Players in 2013
Figure Southeast Asia Generic Drugs Market Size Share by Players in 2017
Table Southeast Asia Generic Drugs Market Size by Application (2013-2018)
Figure Southeast Asia Generic Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Generic Drugs Market Size Share by Application in 2017
Figure India Generic Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table India Generic Drugs Market Size (Million USD) by Players (2013-2018)
Figure India Generic Drugs Market Size Share by Players in 2013
Figure India Generic Drugs Market Size Share by Players in 2017
Table India Generic Drugs Market Size by Application (2013-2018)
Figure India Generic Drugs Revenue Market Share (%) by Application (2013-2018)
Figure India Generic Drugs Market Size Share by Application in 2017
Figure Global Generic Drugs Market Size and Growth Rate (2018-2025)
Table Global Generic Drugs Market Size (Million USD) by Regions (2018-2025)
Figure Global Generic Drugs Market Size Share (2018-2025)
Figure Global Generic Drugs Market Size Share by Regions in 2025
Figure United States Generic Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Europe Generic Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Generic Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Generic Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Generic Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Generic Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Generic Drugs Market Size (Million USD) by Type (2018-2025)
Figure Global Generic Drugs Market Size Share by Type in 2018
Figure Global Generic Drugs Market Size Share by Type in 2025
Table Global Generic Drugs Market Size (Million USD) by Application (2018-2025)
Figure Global Generic Drugs Market Size (Million USD) by Application in 2018


More Publications